With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge

Go back to With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge
(NASDAQ: VBIO) Delayed: 1.12 -0.07 (5.88%)
Previous Close $1.19    52 Week High $1.84 
Open $1.20    52 Week Low $0.61 
Day High $1.20    P/E N/A 
Day Low $1.10    EPS $0.00 
Volume 203,139